Genomic Classification of Cutaneous Melanoma
- PMID: 26091043
- PMCID: PMC4580370
- DOI: 10.1016/j.cell.2015.05.044
Genomic Classification of Cutaneous Melanoma
Abstract
We describe the landscape of genomic alterations in cutaneous melanomas through DNA, RNA, and protein-based analysis of 333 primary and/or metastatic melanomas from 331 patients. We establish a framework for genomic classification into one of four subtypes based on the pattern of the most prevalent significantly mutated genes: mutant BRAF, mutant RAS, mutant NF1, and Triple-WT (wild-type). Integrative analysis reveals enrichment of KIT mutations and focal amplifications and complex structural rearrangements as a feature of the Triple-WT subtype. We found no significant outcome correlation with genomic classification, but samples assigned a transcriptomic subclass enriched for immune gene expression associated with lymphocyte infiltrate on pathology review and high LCK protein expression, a T cell marker, were associated with improved patient survival. This clinicopathological and multi-dimensional analysis suggests that the prognosis of melanoma patients with regional metastases is influenced by tumor stroma immunobiology, offering insights to further personalize therapeutic decision-making.
Copyright © 2015 Elsevier Inc. All rights reserved.
Figures





Similar articles
-
Targeted Genomic Profiling of Acral Melanoma.J Natl Cancer Inst. 2019 Oct 1;111(10):1068-1077. doi: 10.1093/jnci/djz005. J Natl Cancer Inst. 2019. PMID: 30657954 Free PMC article.
-
GAB2 amplifications refine molecular classification of melanoma.Clin Cancer Res. 2009 Jul 1;15(13):4288-91. doi: 10.1158/1078-0432.CCR-09-0280. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509136 Free PMC article.
-
Spectrum and Frequency of BRAF Mutations in Skin Melanomas in the Dalmatian Region of Croatia.Acta Dermatovenerol Croat. 2024 Mar;32(1):75-76. Acta Dermatovenerol Croat. 2024. PMID: 38946192
-
A Review of Melanoma Subtypes: Genetic and Treatment Considerations.J Surg Oncol. 2025 Mar;131(3):356-364. doi: 10.1002/jso.27953. Epub 2024 Oct 16. J Surg Oncol. 2025. PMID: 39415471 Free PMC article. Review.
-
The NF1 gene in tumor syndromes and melanoma.Lab Invest. 2017 Feb;97(2):146-157. doi: 10.1038/labinvest.2016.142. Epub 2017 Jan 9. Lab Invest. 2017. PMID: 28067895 Free PMC article. Review.
Cited by
-
UV-Induced Somatic Mutations Driving Clonal Evolution in Healthy Skin, Nevus, and Cutaneous Melanoma.Life (Basel). 2022 Aug 29;12(9):1339. doi: 10.3390/life12091339. Life (Basel). 2022. PMID: 36143375 Free PMC article. Review.
-
Current State of Target Treatment in BRAF Mutated Melanoma.Front Mol Biosci. 2020 Jul 14;7:154. doi: 10.3389/fmolb.2020.00154. eCollection 2020. Front Mol Biosci. 2020. PMID: 32760738 Free PMC article. Review.
-
Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial.JAMA Oncol. 2016 Aug 1;2(8):1056-64. doi: 10.1001/jamaoncol.2016.0509. JAMA Oncol. 2016. PMID: 27124486 Free PMC article. Clinical Trial.
-
An Immunometabolic Shift Modulates Cytotoxic Lymphocyte Activation During Melanoma Progression in TRPA1 Channel Null Mice.Front Oncol. 2021 May 10;11:667715. doi: 10.3389/fonc.2021.667715. eCollection 2021. Front Oncol. 2021. PMID: 34041030 Free PMC article.
-
Gender and melanoma subtype-based prognostic implications of MUC16 and TTN co-occurrent mutations in melanoma: A retrospective multi-study analysis.Cancer Med. 2024 Sep;13(17):e70199. doi: 10.1002/cam4.70199. Cancer Med. 2024. PMID: 39240165 Free PMC article.
References
-
- Andersen LB, Fountain JW, Gutmann DH, Tarlé SA, Glover TW, Dracopoli NC, Housman DE, Collins FS. Mutations in the neuro-fibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet. 1993;3:118–121. - PubMed
-
- Azimi F, Scolyer RA, Rumcheva P, Moncrieff M, Murali R, McCarthy SW, Saw RP, Thompson JF. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol. 2012;30:2678–2683. - PubMed
-
- Baade P, Meng X, Youlden D, Aitken J, Youl P. Time trends and latitudinal differences in melanoma thickness distribution in Australia, 1990-2006. Int J Cancer. 2012;130:170–178. - PubMed
Publication types
MeSH terms
Grants and funding
- U24 CA143882/CA/NCI NIH HHS/United States
- U24 CA143866/CA/NCI NIH HHS/United States
- U24 CA143843/CA/NCI NIH HHS/United States
- U24 CA143858/CA/NCI NIH HHS/United States
- U24 CA143848/CA/NCI NIH HHS/United States
- U24 CA143883/CA/NCI NIH HHS/United States
- 21141/CRUK_/Cancer Research UK/United Kingdom
- U24 CA143867/CA/NCI NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- P30 CA016672/CA/NCI NIH HHS/United States
- U54 HG003067/HG/NHGRI NIH HHS/United States
- U24 CA143835/CA/NCI NIH HHS/United States
- U24 CA143845/CA/NCI NIH HHS/United States
- U24 CA143799/CA/NCI NIH HHS/United States
- T32 GM007753/GM/NIGMS NIH HHS/United States
- U54 HG003273/HG/NHGRI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- U24 CA144025/CA/NCI NIH HHS/United States
- R01 CA163896/CA/NCI NIH HHS/United States
- U24 CA180951/CA/NCI NIH HHS/United States
- U24 CA143840/CA/NCI NIH HHS/United States
- P50 CA121974/CA/NCI NIH HHS/United States
- U54 HG003079/HG/NHGRI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous